missing translation for 'onlineSavingsMsg'
Learn More

GPR120 Agonist 2, MedChemExpress

Código de producto. 16490737
Encompass_Preferred
Cambiar vista
Click to view available options
Cantidad:
5 mg
10 mg
50 mg
100 mg
Tamaño de la unidad:
10 miligramos
100 miligramos
5 miligramos
50 miligramos
4 product options available for selection
Product selection table with 4 available options. Use arrow keys to navigate and Enter or Space to select.
Código de producto. Cantidad unitSize
16490737 50 mg 50 miligramos
16477147 5 mg 5 miligramos
16455316 100 mg 100 miligramos
16444428 10 mg 10 miligramos
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 4 options available.
4 options
Este artículo no se puede devolver. Vea la política de devoluciones
Código de producto. 16490737 Proveedor Medchem Express N.º de proveedor HY111353

Please to purchase this item. Need a web account? Register with us today!

Este artículo no se puede devolver. Vea la política de devoluciones

MedChemExpress GPR120 Agonist 2 is a GPR120 agonist extracted from patent US 20110313003 A1, example 209.

GPR120 Agonist 2 is a GPR120 agonist extracted from patent US 20110313003 A1, example 209.

Specifications

Nombre del producto químico o material GPR120 Agonist 2
CAS 1234844-11-1
Color Blanco
Notas de grado de pureza Research
Fórmula molecular C22H25ClO4
Cantidad 50 mg
Información de solubilidad DMSO : ≥ 50 mg/mL (128.57 mM)
SMILES O=C(O)CCC1=CC=C(OCC2=C(OC(C)(C)C3)C3=CC(Cl)=C2)C(C)=C1C
Peso molecular (g/mol) 388.88
Formula Weight (peso de la fórmula) 388.88
Porcentaje de pureza 99.07%
Grado Research
Forma física Solid
Para utilizar con (aplicación) Metabolism-sugar/lipid metabolism
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.